Cargando…

HPGDS is a novel prognostic marker associated with lipid metabolism and aggressiveness in lung adenocarcinoma

BACKGROUND: Lung adenocarcinoma (LUAD) is the most common respiratory globallywith a poor prognosis. Lipid metabolism is extremely important for the occurrence and development of cancer. However, the role of genes involved in lipid metabolism in LUAD development is unclear. We aimed to identify the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shao, Fengling, Mao, Huajie, Luo, Tengling, Li, Qijun, Xu, Lei, Xie, Yajun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618883/ https://www.ncbi.nlm.nih.gov/pubmed/36324576 http://dx.doi.org/10.3389/fonc.2022.894485

Ejemplares similares

GDPD5 Related to Lipid Metabolism Is a Potential Prognostic Biomarker in Neuroblastoma
por: Luo, Tengling, et al.
Publicado: (2022)

Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for Glioma
por: Xu, Lei, et al.
Publicado: (2022)

Prognostic signature of lipid metabolism associated LncRNAs predict prognosis and treatment of lung adenocarcinoma
por: Zhao, Jie, et al.
Publicado: (2022)

Identification of NAA40 as a Potential Prognostic Marker for Aggressive Liver Cancer Subtypes
por: Koufaris, Costas, et al.
Publicado: (2021)

Augmented Pla2g4c/Ptgs2/Hpgds axis in bronchial smooth muscle tissues of experimental asthma
por: Chiba, Yoshihiko, et al.
Publicado: (2018)

Aggressive surgical management of adenocarcinoma of the rete testis
por: Maganty, Avinash, et al.
Publicado: (2017)

Overexpressing HPGDS in adipose-derived mesenchymal stem cells reduces inflammatory state and improves wound healing in type 2 diabetic mice
por: Ouyang, Long, et al.
Publicado: (2022)

Src: Marker or Actor in Prostate Cancer Aggressiveness
por: Vlaeminck-Guillem, Virginie, et al.
Publicado: (2014)

CCNDBP1, a Prognostic Marker Regulated by DNA Methylation, Inhibits Aggressive Behavior in Dedifferentiated Liposarcoma via Repressing Epithelial Mesenchymal Transition
por: Yang, Lingge, et al.
Publicado: (2021)

GBE1 Is an Independent Prognostic Marker and Associated With CD163(+) Tumor-Associated Macrophage Infiltration in Lung Adenocarcinoma
por: Liang, Yicheng, et al.
Publicado: (2022)

CXCL9 as a Prognostic Inflammatory Marker in Early-Stage Lung Adenocarcinoma Patients
por: Zhang, Yanwei, et al.
Publicado: (2020)

Long Noncoding RNA SNHG7 Is a Diagnostic and Prognostic Marker for Colon Adenocarcinoma
por: Jiang, Chengwei, et al.
Publicado: (2022)

Prognostic Implication of Energy Metabolism-Related Gene Signatures in Lung Adenocarcinoma
por: Mu, Teng, et al.
Publicado: (2022)

The association between serum lipid profile and the prostate cancer risk and aggressiveness
por: Suh, Jungyo, et al.
Publicado: (2023)

Screening microRNAs as potential prognostic biomarkers for lung adenocarcinoma
por: Dai, Hongshuang, et al.
Publicado: (2023)

A distinct lipid metabolism signature of acute myeloid leukemia with prognostic value
por: Li, Ding, et al.
Publicado: (2022)

Prognostic value of lncRNAs related to fatty acid metabolism in lung adenocarcinoma and their correlation with tumor microenvironment based on bioinformatics analysis
por: Pan, Ya-Qiang, et al.
Publicado: (2022)

Identification of Tumor Microenvironment-Related Prognostic lncRNAs in Lung Adenocarcinoma
por: Yuan, Ligong, et al.
Publicado: (2021)

Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma
por: Van Hiep, Nguyen, et al.
Publicado: (2022)

Detection of Circulating Tumor Cells in Resectable Pancreatic Ductal Adenocarcinoma: A Prospective Evaluation as a Prognostic Marker
por: Song, Byeong Geun, et al.
Publicado: (2021)

Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study
por: Striefler, Jana Käthe, et al.
Publicado: (2021)

A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma
por: Ye, Zaisheng, et al.
Publicado: (2021)

Identification of an Individualized Metabolism Prognostic Signature and Related Therapy Regimens in Early Stage Lung Adenocarcinoma
por: Hu, Junjie, et al.
Publicado: (2021)

Development and validation of prognostic models for colon adenocarcinoma based on combined immune-and metabolism-related genes
por: Jiang, Hui-zhong, et al.
Publicado: (2022)

Exploration of Lipid Metabolism in Gastric Cancer: A Novel Prognostic Genes Expression Profile
por: Xiong, Zhen, et al.
Publicado: (2021)

Development and Validation of a Clinical Prognostic Nomogram for Esophageal Adenocarcinoma Patients
por: Shao, Chen-ye, et al.
Publicado: (2021)

Corrigendum: Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma
por: Van Hiep, Nguyen, et al.
Publicado: (2022)

Genomic Network-Based Analysis Reveals Pancreatic Adenocarcinoma Up-Regulating Factor-Related Prognostic Markers in Cervical Carcinoma
por: Kim, Jihye, et al.
Publicado: (2018)

PD-L2 Serves as a Potential Prognostic Biomarker That Correlates With Immune Infiltration and May Predict Therapeutic Sensitivity in Lower-Grade Gliomas
por: Xie, Qijun, et al.
Publicado: (2022)

GPI Is a Prognostic Biomarker and Correlates With Immune Infiltrates in Lung Adenocarcinoma
por: Han, Jiahui, et al.
Publicado: (2021)

Comprehensive Analysis of Prognostic Markers for Acute Myeloid Leukemia Based on Four Metabolic Genes
por: Zhang, Yuanyuan, et al.
Publicado: (2020)

Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma
por: Zhu, Jinfeng, et al.
Publicado: (2022)

Ileal adenocarcinoma in a young pregnant woman: A rare case report
por: Xiao, Chao, et al.
Publicado: (2023)

Fibrinogen-to-prealbumin ratio: A new prognostic marker of resectable pancreatic cancer
por: Li, Chengqing, et al.
Publicado: (2023)

Deregulation of Lipid Metabolism: The Critical Factors in Ovarian Cancer
por: Ji, Zhaodong, et al.
Publicado: (2020)

The Roles of Beclin 1 Expression in Gastric Cancer: A Marker for Carcinogenesis, Aggressive Behaviors and Favorable Prognosis, and a Target of Gene Therapy
por: Zheng, Hua-chuan, et al.
Publicado: (2020)

Glutamine metabolism genes prognostic signature for stomach adenocarcinoma and immune infiltration: potential biomarkers for predicting overall survival
por: Li, Hui, et al.
Publicado: (2023)

NcRNA-regulated CAPZA1 associated with prognostic and immunological effects across lung adenocarcinoma
por: Qin, Tingting, et al.
Publicado: (2023)

Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors
por: Morandi, Andrea, et al.
Publicado: (2017)

Copper metabolism patterns and tumor microenvironment characterization in colon adenocarcinoma
por: Lin, Jianwei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ctvt7hopetc7of0h1t4v1hpj7p